Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06455488

MANAGE-VT Registry - MANAGEment of Ventricular Tachycardia Outcomes Registry

Data collection registry for patients with ventricular tachycardia to help physicians give better care for patients clinically and procedurally.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Ventricular Tachycardia Arrhythmias, Cardiac Brain Diseases Cardiac Conduction System Disease Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Heart Diseases Nervous System Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Stroke Tachycardia Tachycardia, Ventricular Vascular Diseases Ventricular Fibrillation

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

After consent from a patient the research team will input patients data from many different categories. There is a link to the PDF for the consent form, a patients anticoagulant medications will be assessed, their ventricular tachycardia (VT) history will be inputted, and their date of birth and zip code will inputted. The research team will then input any EKG's, echocardiograms, VT ablations, ICD's, S-ICD's, lab results, and comorbidities.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Must be at least 18 years old
  • Must not be

Exclusion criteria

-

Treatment and study plan

Ventricular tachycardia ablation

Procedure

This is a surgical ablation meant to reset patients irregular rhythm back to sinus.

ICD Implant

Device

A pacemaker or defibrillator implant to prevent SCD

Other names: Pacemaker Implant

Antiarrhythmic drug

Drug

Drug therapies

Other names: Statin Therapy, Anticoagulants

EKG

Diagnostic Test

Monitoring EKG testing done on registry patients

Cardioversion

Diagnostic Test

Monitoring cardioversions on registry patients

Echocardiogram

Diagnostic Test

Monitoring echocardiogram testing done on patients

Primary outcomes

  1. Recurrence of Ventricular Tachycardia

    Time frame: July 20, 2020 - Present

    The natural progression of v-tach will be assessed through medical record review

  2. Number of Participants with Risk of Sudden Cardiac Death

    Time frame: July 20, 2020 - Present

    All events of sudden cardiac death that arise from patients with ventricular tachycardia

  3. Prevent Risk of Stroke

    Time frame: July 20, 2020 - Present

    All strokes, transient ischemic and systemic thrombo-embolic events

Study contacts

Contact information is provided by the study sponsor or research team.

Edward M Burke

CONTACT

[email protected]

7737297956

Martin C Burke, DO

CONTACT

[email protected]

7735208322

Sponsors and collaborators

Lead sponsor

CorVita Science Foundation

Other

Registry information

Official study title

MANAGEment of Ventricular Tachycardia Outcomes Registry

Acronym: MANAGE-VT

Important dates

Study start
2020
Primary completion
2030
Study completion
2030
First posted
Jun 12, 2024
Registry last updated
Jun 12, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.